文献速递甲状腺疾病

碘致甲状腺功能亢进症与房颤/房扑长期发生风险

Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该回顾性队列研究纳入美国退伍军人健康管理局1998-2021年间基线促甲状腺激素正常、后续1年内促甲状腺激素异常且此前60天内接受碘对比剂暴露的成人患者44607例,其中2500例(5.6%)发生碘致甲状腺功能亢进症,中位随访3.7年期间房颤/房扑发生率为10.4%。校正社会人口学和心血管危险因素后,碘致甲状腺功能亢进症与房颤/房扑风险升高相关(校正HR 1.19,95%CI 1.06-1.33),女性风险高于男性(女性HR 1.81,95%CI 1.12-2.92;男性HR 1.15,95%CI 1.03-1.30;交互作用P=0.04)。

要点

  • 碘对比剂暴露后发生甲状腺功能亢进症者,房颤/房扑风险较保持甲状腺功能正常者升高(校正HR 1.19,95%CI 1.06-1.33)。
  • 女性碘致甲状腺功能亢进症后房颤/房扑风险(HR 1.81,95%CI 1.12-2.92)高于男性(HR 1.15,95%CI 1.03-1.30),交互作用P=0.04。
  • 碘致甲状腺功能亢进症在44607例退伍军人中发生2500例(5.6%),中位随访3.7年房颤/房扑发生率10.4%。

核心结论

  • 高碘负荷后发生的甲状腺功能亢进症与房颤/房扑发生风险升高相关,尤其在女性中更为明显。
  • 观察到的性别差异需在性别更多样的研究样本中确认,碘致甲状腺功能亢进症后长期心律失常监测的成本效益分析有待评估。

研究设计与样本

  • 回顾性队列研究,数据来自美国退伍军人健康管理局1998-2021年。
  • 纳入年龄≥18岁、基线血清促甲状腺激素(TSH)正常、后续1年内TSH异常且后续TSH检测前60天内接受碘对比剂暴露的患者44607例(平均年龄60.9±14.1岁,88%为男性)。
  • 采用Cox比例风险回归比较碘致甲状腺功能亢进症组与碘致甲状腺功能正常组发生房颤/房扑的校正风险比(HR)及95%CI。

主要发现

  • 44607例退伍军人中2500例(5.6%)发生碘致甲状腺功能亢进症。
  • 中位随访3.7年(四分位距1.9-7.4年)期间房颤/房扑发生率为10.4%。
  • 校正社会人口学和心血管危险因素后,碘致甲状腺功能亢进症组较碘暴露后保持甲状腺功能正常组房颤/房扑风险升高(校正HR 1.19,95%CI 1.06-1.33)。
  • 女性发生房颤/房扑风险高于男性(女性HR 1.81,95%CI 1.12-2.92;男性HR 1.15,95%CI 1.03-1.30;交互作用P=0.04)。

关键数值与推荐

  • 碘致甲状腺功能亢进症定义为碘对比剂暴露后出现的甲状腺功能亢进症,原文基于基线TSH正常、后续TSH异常及碘对比剂暴露时间关系判定。
  • 主要结局为房颤/房扑发生;效应量为校正HR 1.19(95%CI 1.06-1.33)。
  • 性别亚组:女性HR 1.81(95%CI 1.12-2.92),男性HR 1.15(95%CI 1.03-1.30),交互作用P=0.04。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为观察到的性别差异需在性别更多样的研究样本中确认,并建议评估碘致甲状腺功能亢进症后长期心律失常监测的成本效益。

局限性

  • 作者指出观察到的性别差异需在性别更多样的研究样本中确认。
  • 作者指出碘致甲状腺功能亢进症后长期心律失常监测的成本效益分析有待评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Although iodine-induced hyperthyroidism is a potential consequence of iodinated radiologic contrast administration, its association with long-term cardiovascular outcomes has not been previously studied. OBJECTIVE: To investigate the relationships between hyperthyroidism observed after iodine contrast administration and incident atrial fibrillation/flutter. METHODS: Retrospective cohort study of the U.S. Veterans Health Administration (1998-2021) of patients age ≥18 years with a normal baseline serum thyrotropin (TSH) concentration, subsequent TSH <1 year, and receipt of iodine contrast <60 days before the subsequent TSH. Cox proportional hazards regression was employed to ascertain the adjusted hazard ratio (HR) with 95% CI of incident atrial fibrillation/flutter following iodine-induced hyperthyroidism, compared with iodine-induced euthyroidism. RESULTS: Iodine-induced hyperthyroidism was observed in 2500 (5.6%) of 44 607 Veterans (mean ± SD age, 60.9 ± 14.1 years; 88% men) and atrial fibrillation/flutter in 10.4% over a median follow-up of 3.7 years (interquartile range 1.9-7.4). Adjusted for sociodemographic and cardiovascular risk factors, iodine-induced hyperthyroidism was associated with an increased risk of atrial fibrillation/flutter compared with those who remained euthyroid after iodine exposure (adjusted HR 1.19, 95% CI 1.06-1.33). Females were at greater risk for incident atrial fibrillation/flutter than males (females, HR 1.81, 95% CI 1.12-2.92; males, HR 1.15, 95% CI 1.03-1.30; P for interaction = .04). CONCLUSION: Hyperthyroidism following a high iodine load was associated with an increased risk of incident atrial fibrillation/flutter, particularly among females. The observed sex-based differences should be confirmed in a more sex-diverse study sample, and the cost-benefit analysis of long-term monitoring for cardiac arrhythmias following iodine-induced hyperthyroidism should be evaluated.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Inoue K, Guo R, Lee ML, et al. Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter. J Clin Endocrinol Metab. 2023. PMID: 37146179. doi:10.1210/clinem/dgad250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。